Does BELIMUMAB Cause White matter lesion? 10 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of White matter lesion have been filed in association with BELIMUMAB (BENLYSTA). This represents 0.0% of all adverse event reports for BELIMUMAB.
10
Reports of White matter lesion with BELIMUMAB
0.0%
of all BELIMUMAB reports
0
Deaths
3
Hospitalizations
How Dangerous Is White matter lesion From BELIMUMAB?
Of the 10 reports, 3 (30.0%) required hospitalization, and 1 (10.0%) were considered life-threatening.
Is White matter lesion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BELIMUMAB. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does BELIMUMAB Cause?
Product dose omission issue (4,671)
Systemic lupus erythematosus (3,388)
Fatigue (1,650)
Drug ineffective (1,570)
Pain (1,510)
Wrong technique in device usage process (1,347)
Injection site pain (1,279)
Malaise (1,257)
Headache (1,207)
Arthralgia (1,114)
What Other Drugs Cause White matter lesion?
ADALIMUMAB (84)
METHOTREXATE (83)
FINGOLIMOD (71)
CYTARABINE (57)
PREDNISONE (42)
METRONIDAZOLE (41)
LEVETIRACETAM (38)
RITUXIMAB (37)
AMPHOTERICIN B (34)
DAUNORUBICIN (33)
Which BELIMUMAB Alternatives Have Lower White matter lesion Risk?
BELIMUMAB vs BELINOSTAT
BELIMUMAB vs BELUMOSUDIL
BELIMUMAB vs BELVIQ
BELIMUMAB vs BELZUTIFAN
BELIMUMAB vs BEMPEDOIC ACID